Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
Ra Capital Management, L.P. reported a 16.60% stake in Hemab Therapeutics Holdings, Inc. (Schedule 13G)
Event May 4, 2026 · Filed May 11, 2026
Ra Capital Management, L.P. reported a 16.60% stake in Hemab Therapeutics Holdings, Inc., 7,729,773 shares, as a passive investor on May 4, 2026. Filed May 11, 2026 (Schedule 13G).
- Stake
- 16.60%
- Shares
- 7,729,773
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 16.60% | 7,729,773 |
| Peter Kolchinsky | 16.60% | 7,729,773 |
| Rajeev Shah | 16.60% | 7,729,773 |
| RA Capital Healthcare Fund, L.P. | 13.60% | 6,365,783 |
Source
Related
- Hemab Therapeutics Holdings, Inc.
- Ra Capital Management, L.P.
- Hemab Therapeutics Holdings, Inc. shareholders
- Schedule 13G · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Capital International Investors · Aug 12, 2026
- Schedule 13G · Invus Public Equities, L.P. · Aug 7, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026